Document 3237 DOCN M94A3237 TI Soluble CD95 (FAS delta TM) inhibits HIV-related apoptosis. DT 9412 AU Krowka JF; Sheppard HW; Ascher MS; Fitzpatrick P; Kiefer MC; Pavloff N; Barr PJ; VRDL, CA Dept. of Health Services, Berkeley 94704. SO Int Conf AIDS. 1994 Aug 7-12;10(1):121 (abstract no. PA0105). Unique Identifier : AIDSLINE ICA10/94369338 AB OBJECTIVE: To analyze the role of the apoptosis/activation antigen FAS (CD95) in depletion of lymphocytes from HIV-infected (HIV+) individuals. METHODS: Peripheral blood lymphocytes (PBL) from HIV+ and HIV-seronegative (HIV) participants of the San Francisco Men's Health Study were stained with monoclonal antibodies and analyzed by flow cytometry to quantitate CD95 expression. Gel electrophoresis was used to analyze DNA fragmentation in PBL cultured in the presence or absence of a soluble recombinant form of CD95 (FAS delta TM). RESULTS: Expression of CD95 was significantly increased on the surfaces of both CD4+ and CD8+ PBL from HIV+ donors in comparison to HIV controls. Enhanced CD95 expression on CD4+ PBL Showed a strong negative correlation with CD4+ PBL numbers in HIV+ individuals. FAS delta TM but not control baculovirus extracts blocked completely DNA fragmentation of mitogen-stimulated PBL. CONCLUSIONS: Upregulation of CD95 expression on PBL occurs in HIV+ donors and may be involved in CD4+ lymphocyte depletion. FAS delta TM can inhibit lymphocyte apoptosis. Studies to determine the mechanisms by which HIV affects expression of soluble and/or membrane-associated CD95 are currently in progress. DE Antigens, CD/*PHYSIOLOGY Antigens, CD4/PHYSIOLOGY Antigens, CD8/PHYSIOLOGY Antigens, Surface/*BIOSYNTHESIS *Apoptosis Comparative Study Flow Cytometry Human *HIV Seronegativity HIV Seropositivity/*IMMUNOLOGY Lymphocytes/*IMMUNOLOGY/MICROBIOLOGY Receptors, Cell Surface/*BIOSYNTHESIS T4 Lymphocytes/MICROBIOLOGY Up-Regulation (Physiology) MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).